BRCA1 and BRCA2 Mutations Diagnostic and Therapeutic Implications

Mutations in the BRCA1/2 genes are the most common cause of hereditary breast and ovarian cancer (HBOC), and HBOC is an autosomal dominant cancer predisposition syndrome. Individuals with HBOC have a high risk for breast and ovarian cancers and a moderate risk for other cancers, such as prostate, pa...

Full description

Saved in:
Bibliographic Details
Other Authors: Valarmathi, Mani T. (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_97315
005 20230215
003 oapen
006 m o d
007 cr|mn|---annan
008 20230215s2023 xx |||||o ||| 0|eng d
020 |a intechopen.100842 
020 |a 9781803568072 
020 |a 9781803568065 
020 |a 9781803568089 
040 |a oapen  |c oapen 
024 7 |a 10.5772/intechopen.100842  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MFN  |2 bicssc 
100 1 |a Valarmathi, Mani T.  |4 edt 
700 1 |a Valarmathi, Mani T.  |4 oth 
245 1 0 |a BRCA1 and BRCA2 Mutations  |b Diagnostic and Therapeutic Implications 
260 |b IntechOpen  |c 2023 
300 |a 1 electronic resource (134 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Mutations in the BRCA1/2 genes are the most common cause of hereditary breast and ovarian cancer (HBOC), and HBOC is an autosomal dominant cancer predisposition syndrome. Individuals with HBOC have a high risk for breast and ovarian cancers and a moderate risk for other cancers, such as prostate, pancreatic, melanoma, and fallopian tube cancers. The goal of screening individuals at high risk of familial cancer is either prevention (such as a change in lifestyle or diet) or early detection of cancer. The identification of BRCA mutation carriers is important, since increased surveillance, drug therapy, and prophylactic surgery can reduce cancer-related morbidity and mortality. In recent years, there has been substantial development in BRCA-associated hereditary breast and/or breast-ovarian cancer research and its clinical applications. In this context, this book consolidates the recent advances in BRCA-related cancer biology and therapeutics, covering a wide spectrum of interrelated topics. Chapters cover a wide range of topics, such as BRCA discovery, BRCA structure and function, BRCA-associated cancers, BRCA genetic testing and counselling, and more. This book is a valuable resource not only for medical and allied health students but also for researchers, clinical and nurse geneticists, genetic counselors, and physician assistants. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Medical genetics  |2 bicssc 
653 |a Pre-clinical medicine: basic sciences 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/11593/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/97315  |7 0  |z DOAB: description of the publication